Healio

Early biologic use may cut rehospitalization risk in immune checkpoint inhibitor colitis

Please provide your email address to receive an email when new articles are posted on . High-dose steroid use independently predicted hospital readmission for patients with immune checkpoint inhibitor ...
ascopubs.org

Risk of Colitis in Patients With Inflammatory Bowel Disease or Microscopic Colitis Exposed to Checkpoint Inhibitors: A National Danish Cohort Study

Changes in Medicaid Enrollment Among Adult Survivors of Childhood Cancer After Medicaid Expansion: A Report From the Childhood Cancer Survivor Study Patients with intestinal inflammatory diseases such ...
Healio

Biologic use for checkpoint inhibitor irAEs still elicits ‘uncertainty’

Please provide your email address to receive an email when new articles are posted on . Glucocorticoids remain the primary option for immune-related adverse events of checkpoint inhibitor therapy in ...
Medscape

GI Side Effects of Immune Checkpoint Inhibitors Linked to Colon Adenoma Risk

PHOENIX — Patients treated for cancer with immune checkpoint inhibitors (ICIs) who develop the drugs’ known side effects of diarrhea and colitis experience increased risk of adenomas in the colon — ...
Medscape

Switch to a Second Janus Kinase Inhibitor Helpful in Ulcerative Colitis

Switching to a second-line Janus kinase (JAK) inhibitor resulted in steroid-free clinical remission in about half of the patients with active ulcerative colitis (UC) after induction; compared with ...